BC Platforms launches BC Catalyst, first-to-market, AI-native analytics product that accelerates precision medicine
BC Catalyst transforms genomic and real-world data into fast, actionable insights to advance precision medicine at scale.
BC Catalyst transforms genomic and real-world data into fast, actionable insights to advance precision medicine at scale.
Zurich – 5th, February 2026 BC Platforms, a global leader in healthcare data, technology, and analytics today announced a strategic partnership with OmicsBank, a healthcare AI-ready data infrastructure company specializing in enabling access to large-scale, research-ready longitudinal and multi-modal real-world clinical and multi-omics datasets from emerging markets. The partnership expands BC Platforms’ global data partner
We partner with GeneVault to expand access to RWD from underrepresented populations across Asia, the Middle East, Africa, and Latin America.
BC Platforms in the press: Signify Research reviews BC Catalyst, our AI-powered platform for life sciences and precision medicine.
Narasimha Kumar joins us as Global Head of Technology Consulting and India Country Head.
BC Platforms in the press: GeneOnline highlights our call to close Asia’s data gap and our role in building secure TREs.
Recognizing our leadership in AI, data analytics and Real-World Data.
BC Platforms in the press: Bio-IT World highlights our view on the role of AI in helping the European Health Data Space deliver secure, harmonized and high-value research.
We welcome two senior leaders: Teresa Ley as SVP of Healthcare and Partnerships for North America and EMEA, and Andrew O’Brien as SVP of Life Sciences and Healthcare Sales for JAPAC.
For press and media inquiries, contact our communications team at media@bcplatforms.com.
For partnerships, business opportunities, and all other inquiries, please fill out this form